Ely Benaim - Net Worth and Insider Trading
Ely Benaim Net Worth
The estimated net worth of Ely Benaim is at least $477,016 dollars as of 2024-11-05. Ely Benaim is the Chief Medical Officer of NovoCure Ltd and owns about 28,672 shares of NovoCure Ltd (NVCR) stock worth over $477,016. Details can be seen in Ely Benaim's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ely Benaim has not made any transactions after 2022-08-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ely Benaim
Ely Benaim Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ely Benaim owns 3 companies in total, including NovoCure Ltd (NVCR) , Rexahn Pharmaceuticals Inc (REXN) , and Opus Genetics Inc (IRD) .
Click here to see the complete history of Ely Benaim’s form 4 insider trades.
Insider Ownership Summary of Ely Benaim
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NVCR | NovoCure Ltd | 2022-08-03 | Chief Medical Officer |
| REXN | Rexahn Pharmaceuticals Inc | 2019-02-28 | Chief Medical Officer |
| IRD | Opus Genetics Inc | 2015-02-02 | Chief Medical Officer |
Ely Benaim Latest Holdings Summary
Ely Benaim currently owns a total of 1 stock. Ely Benaim owns 28,672 shares of NovoCure Ltd (NVCR) as of August 3, 2022, with a value of $477,016.
Latest Holdings of Ely Benaim
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | 2022-08-03 | 28,672 | 16.64 | 477,016 |
Holding Weightings of Ely Benaim
Ely Benaim Form 4 Trading Tracker
According to the SEC Form 4 filings, Ely Benaim has made a total of 14 transactions in NovoCure Ltd (NVCR) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in NovoCure Ltd is the sale of 5,959 shares on August 3, 2022, which brought Ely Benaim around $439,357.
Insider Trading History of Ely Benaim
- 1
Ely Benaim Trading Performance
Ely Benaim Ownership Network
Ownership Network List of Ely Benaim
Ownership Network Relation of Ely Benaim
Ely Benaim Owned Company Details
What does NovoCure Ltd do?
Who are the key executives at NovoCure Ltd?
Ely Benaim is the Chief Medical Officer of NovoCure Ltd. Other key executives at NovoCure Ltd include President & CNS Cancers US Frank X Leonard , Chief Human Resources Officer Michal Nath Puri , and Chief Financial Officer Ashley Cordova .
NovoCure Ltd (NVCR) Insider Trades Summary
Over the past 18 months, Ely Benaim made no insider transaction in NovoCure Ltd (NVCR). Other recent insider transactions involving NovoCure Ltd (NVCR) include a net sale of 5,921 shares made by Wilhelmus Cm Groenhuysen , a net sale of 5,195 shares made by Frank X Leonard , and a net sale of 2,715 shares made by Ashley Cordova .
In summary, during the past 3 months, insiders sold 1,568 shares of NovoCure Ltd (NVCR) in total and bought 0 shares, with a net sale of 1,568 shares. During the past 18 months, 18,348 shares of NovoCure Ltd (NVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 18,348 shares.
NovoCure Ltd (NVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
NovoCure Ltd Insider Transactions
Ely Benaim Mailing Address
Above is the net worth, insider trading, and ownership report for Ely Benaim. You might contact Ely Benaim via mailing address: C/o Rexahn Pharmaceuticals, Inc., 15245 Shady Grove Road, Suite 455, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
